Acumen Pharmaceuticals, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $59.4M | $51.8M | $54.0M | $46.8M | $36.8M | $30.2M | $35.6M | $33.2M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $115.5M | $133.1M | $122.3M | $132.2M | $148.4M | $154.9M | $178.3M | $207.6M |
| Property, Plant & Equipment | $80.0K | $91.0K | $103.0K | $115.0K | $130.0K | $137.0K | $73.0K | $89.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $116.0M | $133.6M | $122.8M | $142.2M | $171.9M | $204.5M | $239.0M | $267.0M |
| Liabilities | ||||||||
| Accounts Payable | $13.4M | $1.7M | $554.0K | $682.0K | $2.1M | $1.1M | $5.6M | $2.3M |
| Total Current Liabilities | $46.8M | $29.2M | $30.0M | $22.0M | $24.9M | $19.3M | $27.6M | $19.9M |
| Long-Term Debt | $11.9M | $16.9M | $22.4M | $27.1M | $29.9M | $29.5M | $29.4M | $29.7M |
| Total Liabilities | $58.7M | $46.2M | $52.4M | $49.0M | $54.8M | $49.0M | $57.2M | $49.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-499.9M | $-467.2M | $-446.5M | $-421.3M | $-394.9M | $-353.9M | $-325.1M | $-288.0M |
| Total Stockholders' Equity | $57.3M | $87.5M | $70.4M | $93.2M | $117.1M | $155.5M | $181.8M | $217.2M |